Literature DB >> 15479867

Pharmacogenetics in the rheumatic diseases.

B N Cronstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15479867      PMCID： PMC1766779          DOI： 10.1136/ard.2004.028217

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

1.  Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis.

Authors:  T Pincus
Journal:  Clin Exp Rheumatol       Date:  1998 Nov-Dec       Impact factor: 4.473

2.  The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.

Authors:  A E van Ede; R F Laan; H J Blom; T W Huizinga; C J Haagsma; B A Giesendorf; T M de Boo; L B van de Putte
Journal:  Arthritis Rheum       Date:  2001-11

3.  Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.

Authors:  A Ravelli; D Migliavacca; S Viola; N Ruperto; A Pistorio; A Martini
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

4.  Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.

Authors:  A E van Ede; R F Laan; M J Rood; T W Huizinga; M A van de Laar; C J van Denderen; T A Westgeest; T C Romme; D J de Rooij; M J Jacobs; T M de Boo; G J van der Wilt; J L Severens; M Hartman; P F Krabbe; B A Dijkmans; F C Breedveld; L B van de Putte
Journal:  Arthritis Rheum       Date:  2001-07

Review 5.  Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines.

Authors:  G K Endresen; G Husby
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

6.  The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.

Authors:  Z Ortiz; B Shea; M E Suarez-Almazor; D Moher; G A Wells; P Tugwell
Journal:  J Rheumatol       Date:  1998-01       Impact factor: 4.666

7.  Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

Authors:  S L Morgan; J E Baggott; J Y Lee; G S Alarcón
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

Review 8.  The use of folates concomitantly with low-dose pulse methotrexate.

Authors:  J B Shiroky
Journal:  Rheum Dis Clin North Am       Date:  1997-11       Impact factor: 2.670

Review 9.  Folate supplementation and methotrexate.

Authors:  B A Dijkmans
Journal:  Br J Rheumatol       Date:  1995-12

10.  Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.

Authors:  J H Yen; B E Moore; T Nakajima; D Scholl; D J Schaid; C M Weyand; J J Goronzy
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307
View more
  1 in total

1.  Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis.

Authors:  Gloris Sánchez; Julio S Castro; Soham Al Snih; Luísa Pérez Blanco; María H Esteva; Ernesto García Macgregor; Marielena González; Ysabel Granados; Francisco Marín; Alexis Rosas; Antonio Tristano; Esther Chirinos; Luís Mundaraín; Gilberto Sanoja; Guisela Zambrano-Marín; Martín A Rodríguez
Journal:  Rheumatol Int       Date:  2006-11-11       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.